Galera Therapeutics, Inc. (GRTX) NASDAQ

0.04

-0.001(-2.22%)

Updated at February 05 10:30AM

Currency In USD

Valuation

Market Cap6.48M
Enterprise Value-10.53M
P/E Ratio-0.12
PEG Ratio-0
Price/Sales Ratio37.73
Price/Book Ratio-0.02
Enterprise/Revenue-58.35
Enterprise/EBITDA0.27

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-222.88
Operating Margin-225.8

Management Effectiveness

Return On Assets-2.2
Return On Equity0.14

Income Statement

Revenue0
Revenue/Share0
Gross Profit-259,000
EBITDA-46.69M
Net Income-59.08M
Diluted EPS-1.33

Balance Sheet

Total Cash8.46M
Total Cash/Share0.16
Total Debt0
Total Debt/Equity0
Current Ratio9.74
Book Value Per Share-2.63

Price History

52-Week Change-73.76
52-Week High0.29
52-Week Low0.02
Moving Average 50 Days0.04
Moving Average 200 Days0.09

Statistics

Average Volume212,816
Shares Outstanding75.46M
% Held by Institutions0.1

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A